Clinical investigators are assessing the efficacy of a novel direct oral anticoagulant for the prevention of deep vein thrombosis (DVT) following total knee arthroplasty in a double-blind, placebo-controlled trial. The published results indicate that the new medication provides a Relative Risk Reduction (RRR) of compared to the placebo group. The authors also report that the Number Needed to Treat (NNT) to prevent one DVT event is .
Based on these findings, which of the following best represents the incidence of DVT in the placebo group?
- A
- B
- C
- Cevap
- E
Cevap
The correct answer is .
The correct answer accurately links the formulas for Number Needed to Treat (NNT) and Relative Risk Reduction (RRR) to find the baseline incidence. First, the Absolute Risk Reduction (ARR) is calculated as , which equals or (). Because RRR is defined as the ARR divided by the baseline incidence (incidence in the placebo group), rearranging the formula gives: Baseline Incidence = . Substituting the values yields , or .
Adım Adım Çözüm
Anahtar Kavram
Deriving baseline incidence (Control Event Rate) using the relationships between Number Needed to Treat (NNT), Absolute Risk Reduction (ARR), and Relative Risk Reduction (RRR).
Tahmini Süre:2m 0s